TP53 and MDM2 Polymorphisms and the Risk of Endometrial Cancer in Postmenopausal Women
Medical Oncology - United States
doi 10.1007/s12032-014-0286-z
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2014
Authors
Publisher
Springer Science and Business Media LLC